Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Common Equity (2016 - 2026)

Inogen has reported Common Equity over the past 14 years, most recently at $192.2 million for Q4 2025.

  • Quarterly Common Equity rose 10.57% to $192.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $192.2 million through Dec 2025, up 10.57% year-over-year, with the annual reading at $192.2 million for FY2025, 10.57% up from the prior year.
  • Common Equity was $192.2 million for Q4 2025 at Inogen, down from $197.2 million in the prior quarter.
  • Over five years, Common Equity peaked at $390.9 million in Q3 2021 and troughed at $173.9 million in Q4 2024.
  • The 5-year median for Common Equity is $252.7 million (2023), against an average of $268.4 million.
  • Year-over-year, Common Equity grew 10.9% in 2021 and then plummeted 34.26% in 2023.
  • A 5-year view of Common Equity shows it stood at $370.2 million in 2021, then dropped by 19.67% to $297.4 million in 2022, then crashed by 31.13% to $204.8 million in 2023, then dropped by 15.11% to $173.9 million in 2024, then grew by 10.57% to $192.2 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's Common Equity are $192.2 million (Q4 2025), $197.2 million (Q3 2025), and $199.5 million (Q2 2025).